Literature DB >> 2046135

Tuberculous pericarditis.

N O Fowler1.   

Abstract

Tuberculosis is responsible for approximately 4% of cases of acute pericarditis, 7% of cases of cardiac tamponade, and, in older studies, 6% of instances of constrictive pericarditis. However, in some nonindustrialized countries, tuberculosis is a leading cause of pericarditis. The diagnosis is based on demonstration of tubercle bacilli in pericardial fluid or on histologic section of the pericardium, or proof of tuberculosis elsewhere in a patient with otherwise unexplained pericarditis. Treatment consists of triple drug therapy for at least 9 months (isoniazid, rifampin, and streptomycin or ethambutol). Pyrazinamide can be used for the first 2 months, and the total therapeutic period can then be shortened to 6 months after culture conversion. Three months of corticosteroid therapy may be useful in patients in whom pericardial effusion persists or recurs despite the use of antituberculous drugs. Surgical resection of the pericardium is indicated for recurrent or life-threatening tamponade, or when there is persistent elevation of systemic venous pressure unrelieved by pericardiocentesis. As many as one third to one half of patients will eventually require pericardiectomy despite adequate drug therapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2046135

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  33 in total

Review 1.  Diagnosis of tuberculous aetiology in pericardial effusions.

Authors:  G Cherian
Journal:  Postgrad Med J       Date:  2004-05       Impact factor: 2.401

2.  Can tuberculosis still act as a hidden killer?

Authors:  Razia Aftab
Journal:  Int J Health Sci (Qassim)       Date:  2007-01

Review 3.  Tuberculous pericarditis with and without HIV.

Authors:  Mpiko Ntsekhe; Bongani M Mayosi
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

4.  Constrictive pericarditis treated by surgery.

Authors:  Alireza A Ghavidel; Maziar Gholampour; Majid Kyavar; Yalda Mirmesdagh; Mohammad-Bagher Tabatabaie
Journal:  Tex Heart Inst J       Date:  2012

5.  Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients.

Authors:  J G Hakim; I Ternouth; E Mushangi; S Siziya; V Robertson; A Malin
Journal:  Heart       Date:  2000-08       Impact factor: 5.994

6.  Tuberculous pericarditis with rapid progression to constriction. Prompt diagnosis and treatment are needed.

Authors:  C P Clifford; G J Davies; J Scott; S Shaunak; J Sarvill; J B Schofield
Journal:  BMJ       Date:  1993-10-23

7.  Chronic constrictive pericarditis: unique cause of heart failure in a child with tetralogy of Fallot.

Authors:  Saurabh Kumar Gupta; Anita Saxena; Sachin Talwar
Journal:  Pediatr Cardiol       Date:  2011-09-13       Impact factor: 1.655

8.  Tuberculous myopericarditis: a rare presentation in an immunocompetent host.

Authors:  Nayan Desai; Shivang Desai; Udit Chaddha; Brian Gable
Journal:  BMJ Case Rep       Date:  2013-03-01

9.  Tuberculous pericarditis as the first manifestation of AIDS.

Authors:  J Pedro-Botet; T Auguet; J Coll; S Pons; J Rubiés-Prat
Journal:  Infection       Date:  1993 Sep-Oct       Impact factor: 3.553

10.  Predictors of constrictive pericarditis after tuberculous pericarditis.

Authors:  P K Suwan; S Potjalongsilp
Journal:  Br Heart J       Date:  1995-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.